# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-027982
Filing Date
2021-11-12
Accepted
2021-11-12 06:34:04
Documents
68
Period of Report
2021-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-q.htm iXBRL | 10-Q | 2242503
2 |  | ex31-1.htm | EX-31.1 | 18286
3 |  | ex31-2.htm | EX-31.2 | 18373
4 |  | ex32-1.htm | EX-32.1 | 6303
5 |  | ex32-2.htm | EX-32.2 | 6174
| Complete submission text file | 0001493152-21-027982.txt |  | 9770312

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | mymd-20210930.xsd | EX-101.SCH | 64635
7 | INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | mymd-20210930_cal.xml | EX-101.CAL | 50557
8 | INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | mymd-20210930_def.xml | EX-101.DEF | 281444
9 | INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | mymd-20210930_lab.xml | EX-101.LAB | 484000
10 | INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | mymd-20210930_pre.xml | EX-101.PRE | 375478
11 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 2008515

Mailing Address 855 N. WOLFE STREET SUITE 623 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 623 BALTIMORE MD 21205 856-848-8698
MyMD Pharmaceuticals, Inc. (Filer) CIK: 0001321834 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36268 | Film No.: 211399304
SIC: 2835 In Vitro & In Vivo Diagnostic Substances